Filimoniuk, A., Blachnio-Zabielska, A., Imierska, M., Lebensztejn, D. M., & Daniluk, U. (2020). Sphingolipid Analysis Indicate Lactosylceramide as a Potential Biomarker of Inflammatory Bowel Disease in Children. Biomolecules.
Chicago Style aipamenaFilimoniuk, Aleksandra, Agnieszka Blachnio-Zabielska, Monika Imierska, Dariusz Marek Lebensztejn, and Urszula Daniluk. "Sphingolipid Analysis Indicate Lactosylceramide As a Potential Biomarker of Inflammatory Bowel Disease in Children." Biomolecules 2020.
MLA aipamenaFilimoniuk, Aleksandra, et al. "Sphingolipid Analysis Indicate Lactosylceramide As a Potential Biomarker of Inflammatory Bowel Disease in Children." Biomolecules 2020.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.